Quent Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-391
| Closed | -$53.5K | – | 390 |
|
|
2025
Q1 | $53.5K | Buy |
391
+93
| +31% | +$12.7K | 0.01% | 539 |
|
|
2024
Q4 | $45.6K | Buy |
298
+72
| +32% | +$11K | ﹤0.01% | 602 |
|
|
2024
Q3 | $43.9K | Sell |
226
-69
| -23% | -$13.4K | ﹤0.01% | 702 |
|
|
2024
Q2 | $68.4K | Buy |
295
+40
| +16% | +$9.27K | 0.01% | 573 |
|
|
2024
Q1 | $55K | Sell |
255
-82
| -24% | -$17.7K | 0.01% | 640 |
|
|
2023
Q4 | $87.2K | Buy |
337
+49
| +17% | +$12.7K | 0.01% | 484 |
|
|
2023
Q3 | $74K | Sell |
288
-4
| -1% | -$1.03K | 0.01% | 492 |
|
|
2023
Q2 | $83.2K | Buy |
292
+7
| +2% | +$1.99K | 0.01% | 466 |
|
|
2023
Q1 | $79.2K | Buy |
285
+7
| +3% | +$1.94K | 0.01% | 469 |
|
|
2022
Q4 | $77K | Buy |
278
+23
| +9% | +$6.37K | 0.01% | 471 |
|
|
2022
Q3 | $68K | Buy |
255
+25
| +11% | +$6.67K | 0.01% | 463 |
|
|
2022
Q2 | $47K | Buy |
230
+35
| +18% | +$7.15K | 0.01% | 531 |
|
|
2022
Q1 | $41K | Sell |
195
-125
| -39% | -$26.3K | 0.01% | 644 |
|
|
2021
Q4 | $77K | Buy |
+320
| New | +$77K | 0.02% | 456 |
|